Attitudes towards being offered a choice of self-sampling or clinician sampling for cervical screening: A cross-sectional survey of women taking part in a clinical validation of HPV self-collection devices
- PMID: 39383889
- PMCID: PMC12106923
- DOI: 10.1177/09691413241283356
Attitudes towards being offered a choice of self-sampling or clinician sampling for cervical screening: A cross-sectional survey of women taking part in a clinical validation of HPV self-collection devices
Abstract
ObjectivesPrimary human papillomavirus (HPV) testing in cervical screening offers the opportunity for women to be given a choice between HPV self-sampling and traditional clinician screening. This study assessed attitudes towards a choice and anticipated future preference among women who had collected a vaginal self-sample alongside their usual cervical screen.SettingThirty-eight general practices across five areas in England.MethodsOverall, 2323 women (24-65 years; response rate: 48%) completed a survey after collecting a self-sample and having a clinician screen at their GP practice. We asked which test they preferred and assessed attitudes to being offered a choice. We explored age, education, ethnicity and screening experience as predictors of attitudes towards a choice and anticipated future choice.ResultsMost participants felt they would like a choice between self-sampling and clinician screening (85%) and thought this would improve screening for them (72%). However, 23% felt it would be difficult to choose, 15% would worry about making a choice, and nearly half would prefer a recommendation (48%). Compared with women with degree-level education, those with fewer qualifications were more likely to say they would worry about having a choice or would not want a choice (p < 0.001). The majority said they would choose to self-sample at home if offered a choice in the future (69%; n = 1602/2320).ConclusionsSelf-sampling is likely to be popular, but offering a choice could cause worry for some people and many would prefer a recommendation. Supporting people to make a choice will be important, particularly for those with lower levels of education.
Keywords: HPV; cancer screening; decision-making; human papillomavirus; public attitudes.
Conflict of interest statement
Declaration of conflicting interestsJW received travel, subsistence and consultancy fees (to her institution) from Hologic (manufacturers of an HPV self-sample kit) to attend a cervical cancer patient advocacy meeting in May 2024. The other authors declare no conflicts of interest.
Similar articles
-
The levels of women's awareness, experience, acceptability and preference for Vaginal Human Papillomavirus (HPV) self-sampling in three provinces of China: a cross-sectional study.BMC Womens Health. 2024 Jun 15;24(1):343. doi: 10.1186/s12905-024-03186-w. BMC Womens Health. 2024. PMID: 38877469 Free PMC article.
-
Feasibility and acceptability of human papillomavirus self-sampling compared with clinician sampling in urban areas of western China: a cross-sectional survey.Front Public Health. 2025 Apr 23;13:1524796. doi: 10.3389/fpubh.2025.1524796. eCollection 2025. Front Public Health. 2025. PMID: 40337741 Free PMC article.
-
The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.Cancer Prev Res (Phila). 2021 Jan;14(1):105-112. doi: 10.1158/1940-6207.CAPR-20-0280. Epub 2020 Sep 11. Cancer Prev Res (Phila). 2021. PMID: 32917643
-
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.Lancet Oncol. 2014 Feb;15(2):172-83. doi: 10.1016/S1470-2045(13)70570-9. Epub 2014 Jan 14. Lancet Oncol. 2014. PMID: 24433684 Review.
-
High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.Int J Cancer. 2013 May 15;132(10):2223-36. doi: 10.1002/ijc.27790. Epub 2012 Sep 14. Int J Cancer. 2013. PMID: 22907569 Review.
Cited by
-
Beliefs and Perceptions in Attending the Cervical Screening: The COMUNISS Project Experience.Cancers (Basel). 2025 Jan 9;17(2):190. doi: 10.3390/cancers17020190. Cancers (Basel). 2025. PMID: 39857972 Free PMC article.
-
Recommendations for a Communication Strategy to Support Informed Decision-Making About Self or Clinician Sampling for Cervical Screening in the UK: Qualitative Study.Health Expect. 2025 Apr;28(2):e70191. doi: 10.1111/hex.70191. Health Expect. 2025. PMID: 40150899 Free PMC article.
-
Enhancing equity and efficiency in cervical screening uptake: a multidisciplinary quality improvement initiative.BMJ Open Qual. 2025 Aug 11;14(3):e003111. doi: 10.1136/bmjoq-2024-003111. BMJ Open Qual. 2025. PMID: 40789718 Free PMC article.
References
-
- NHS. When you'll be invited for cervical screening 2023, https://www.nhs.uk/conditions/cervical-screening/when-youll-be-invited/
-
- NHS Digital. Cervical Screening Programme, England - 2022-2023 Official statistics, National statistics 2023, https://digital.nhs.uk/data-and-information/publications/statistical/cer...
-
- Waller J, Bartoszek M, Marlow Let al. et al. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen 2009; 16: 199–204. - PubMed